A woman from Louisiana has filed a Lipitor lawsuit, alleging that she developed type-2 diabetes after taking Lipitor, a well-known cholesterol drug that is part of a class of drugs known as statins. The woman claims she took Lipitor for 10 years. The Lipitor lawsuit filed also alleges that for years, Pfizer withheld knowledge about the diabetes risk associated with Lipitor.
It wasn’t until 2011, the complaint alleges, that the U.S. Food and Drug Administration (FDA) conducted an investigation into Lipitor and other statin drugs. After the investigation, the FDA issued a consumer update concerning statins; it was ultimately concluded that statin drugs were in fact linked to causing complications with glucose levels in the blood. The FDA slammed Pfizer for failing to disclose Lipitor’s risks and the agency requested a change be made to the drug’s warning label.
Yet despite Lipitor’s label change in 2011, Lipitor’s label still fails to adequately warn of the type-2 diabetes risk associated with Lipitor, the Lipitor lawsuit alleges.
“Despite a growing body of evidence associating Lipitor with type-2 diabetes, many are still unaware of the risk and continue to expose themselves every day, “ commented Daniel Nigh, a Lipitor lawyer with the Levin, Papantonio law firm.
Lipitor has recently been under scrutiny as a number of Lipitor lawsuits have been filed against Pfizer alleging that the drug caused patients to develop type-2 diabetes. Several studies have also concluded that Lipitor is associated with causing type-2 diabetes. In addition to being linked to diabetes, the drug has also been associated with causing memory loss and myopathy (severe muscle damage) in patients.
Lipitor is one of the best-selling statin drugs on the market and is commonly prescribed to individuals for maintaining their cholesterol. Statins are also prescribed to potentially lower the risk of stroke, heart attack, and fatal blood clots.